S. Ellis

Improved survival among patients treated with adjuvant tamoxifen after mastectomy for early breast cancer.

K. McPherson, M. Baum, D. Brinkley, 1983, Lancet.

IMPROVED SURVIVAL AMONGST PATIENTS TREATED WITH ADJUVANT TAMOXIFEN AFTER MASTECTOMY FOR EARLY BREAST CANCER

Michael Baum, M. Baum, D. Brinkley, 1983, The Lancet.

Six-year results of a controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer

K. McPherson, M. Baum, D. Brinkley, 1985, World Journal of Surgery.

Cemiplimab in advanced cutaneous squamous cell carcinoma: the UK experience from the Named Patient Scheme

Simon C Watkins, S. Ellis, K. Fife, 2022, Journal of the European Academy of Dermatology and Venereology : JEADV.

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

C. Tournigand, M. Espié, B. Weber, 2019, The Lancet.